Russo Rene
SEC insider (Form 3/4/5 filer). CIK 0001722066. PRESIDENT AND CEO at Xilio Therapeutics, Inc. (XLO). 23 reported Form 4/5 transactions since Sep 2024; latest on Jan 1, 2026. Located in WALTHAM, MA.
Companies Russo Rene has filed insider reports for
- Xilio Therapeutics, Inc. (XLO): Director, Officer, PRESIDENT AND CEO
Russo Rene
CIK: 0001722066
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Xilio Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Jan 1, 2026XLO
Xilio Therapeutics, Inc.
ExerciseDirect44.3K shares- - Dec 31, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
1.5M shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
135.1K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
473.3K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
2.1M shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
239.7K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
473.3K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
239.7K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
135.1K shares- - Nov 21, 2025XLO
Xilio Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
50K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 1, 2026 | XLO Xilio Therapeutics, Inc. | Exercise | 44,250 | - | $0 | Direct |
| Dec 31, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 1,500,258 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 135,134 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 473,334 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 2,075,000 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Disposition Stock Option (right to buy) | 239,703 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Disposition Stock Option (right to buy) | 473,334 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 239,703 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Disposition Stock Option (right to buy) | 135,134 | - | - | Direct |
| Nov 21, 2025 | XLO Xilio Therapeutics, Inc. | Disposition Stock Option (right to buy) | 50,041 | - | - | Direct |
1-10 of 23 transactions